SDS.WA Stock Analysis
SD
Uncovered
Sds Optic SA is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
SDS Optic SA engages in the development of biochemistry, engineering, and fiber optic technologies solutions, which can be used in cancer diagnosis and treatment. The company is headquartered in Lublin, Woj. Lubelskie. The company went IPO on 2022-03-15. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The firm tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The firm is also engaged in research regarding different kinds of diseases such as fungal diseases. The firm cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.